通过IRF4介导的Treg表型切换可以加剧高氧诱导的膜上皮细胞损伤
He Langyue1, Zhu Ying1, Jiang Jianfeng1
1Department of Pediatrics, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, Jiangsu, China.
BMC pulmonary medicine
|March 16, 2024
概括
干扰素调节因子4 (IRF4) 通过促进调节性T细胞 (Treg) 切换,加剧支气管肺张症 (BPD) 中的肺损伤. 在小鼠模型中,IRF4淘汰会防止高氧诱导的BPD.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 支气管肺功能障碍症 (BPD) 涉及气囊管功能障碍症和炎症性肺部疾病.
- 干扰素调节因子4 (IRF4) 与炎症性肺部疾病有关,但其在BPD中的作用尚不清楚.
研究的目的:
- 研究IRF4在BPD病变发生过程中的作用和机制.
- 阐明IRF4如何影响T细胞调节 (Treg) 现型切换在过氧诱导的BPD中.
主要方法:
- 通过高氧暴露建立了BPD的小鼠模型.
- 使用ELISA,西式涂抹和流动细胞计量来分析肺组织标记物,包括IRF4,IL-17A,IL-6,SP-C,T1α,FOXP3+Tregs和FOXP3+RORγt+Tregs.
- 检查了IRF4淘汰赛小鼠,暴露于高氧,以评估IRF4的特定效应.
主要成果:
- 在BPD小鼠中,肺部结构有障碍,IRF4,IL-17A,IL-6和FOXP3+RORγt+Tregs增加,但SP-C,T1α和FOXP3+Tregs减少.
- 暴露于高氧的IRF4淘汰小鼠表现出肺部结构正常化,SP-C和T1α增加,IL-17A和IL-6减少,Treg群体向FOXP3+Tregs转移.
- 在过氧诱导的Treg表型切换中,IRF4起着至关重要的作用.
结论:
- 在高氧化下,IRF4介导的Treg表型切换会在BPD中加剧膜上皮细胞损伤.
- 向IRF4可能通过调节Treg反应和保护肺组织,为BPD提供治疗策略.
更多相关视频
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Acute Respiratory Failure-II
222
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
222


